Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine for Mucosal Healing in Ulcerative Colitis
NCT02579733Phase 4Terminated
- Sponsor
- Kyungpook National University Hospital
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azathioprine in ulcerative colitis (UC) (2 arms), sponsored by Kyungpook National University Hospital. Primary endpoint: Mucosal healing status at 1 year. Started Feb 2016; status: terminated.
02
Drugs
azathioprine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02579733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02579733.